What about using vitamin c for pancreatic cancer

Vitamin C for Pancreatic Cancer: What the Research Shows

Great question — this is an area of active research with some promising early findings. Let me break down what we know.

How Vitamin C Works Against Pancreatic Cancer

The key insight is that high-dose intravenous (IV) vitamin C works differently than oral supplements you'd buy at a store.

The mechanism: According to research highlighted by Let's Win Pancreatic Cancer, pancreatic cancer cells with KRAS mutations (found in over 90% of pancreatic cancers) have a vulnerability:

• These cancer cells produce huge amounts of a protein called GLUT1 that transports glucose (sugar) into the cell
• GLUT1 also accidentally transports the oxidized form of vitamin C (called dehydroascorbic acid or DHA) into cancer cells
• Once inside, the DHA acts like a "Trojan horse" — it depletes the cell's natural antioxidants, causing the cancer cell to die from oxidative stress
• Healthy cells are largely spared because they don't have the same GLUT1 overexpression

Important: Oral vitamin C supplements won't work for this — you'd need 10 grams of vitamin C (equivalent to 300 oranges!) to achieve therapeutic levels. Only IV administration creates the high blood concentrations needed.

---

What Clinical Trials Show

Phase II Trial Results (2024)

According to a University of Iowa study published in Redox Biology (November 2024):

Vitamin C + Standard Chemotherapy:

• Overall survival: 16 months (compared to 8 months with chemotherapy alone)
• Progression-free survival: 6 months (compared to 4 months with chemo alone)
• Study design: 34 patients with stage IV metastatic pancreatic cancer
• Chemotherapy used: Gemcitabine and nab-paclitaxel
• Vitamin C dose: 75 grams IV, three times per week
• Safety: No serious adverse effects; patients reported better quality of life and could tolerate treatment longer

The results were so promising that researchers stopped the trial early.

Ongoing Clinical Trials

Multiple institutions are testing high-dose vitamin C, including:

• Weill Cornell Medicine — testing IV vitamin C in patients with KRAS or BRAF mutations
• Multiple cohorts studying resectable (removable) tumors and metastatic disease

---

Important Context & Limitations

Why this matters: According to Dr. [removed] Cullen (University of Iowa), "Treatments for breast cancer and lung cancer have greatly improved, but pancreatic cancer has just been left behind." Even doubling survival time from 8 to 16 months represents meaningful progress for this aggressive disease.

Current challenges:

• The Phase II trial was small (34 patients) and needs larger Phase III confirmation
• Vitamin C is not patentable, so pharmaceutical companies have little financial incentive to fund large trials
• Many oncologists remain skeptical due to failed oral vitamin C trials from the 1980s (Mayo Clinic studies)
• A Phase III trial would need ~90 patients from multiple sites and significant funding

What researchers emphasize: Vitamin C alone won't cure cancer — it appears to work best in combination with chemotherapy.

---

STEP 3: Questions to Ask Your Oncologist

If you're interested in exploring this approach, here are specific questions:

1. "Has my tumor been tested for KRAS mutations? Do I have genetic profiling results?" (This helps determine if you might benefit)

2. "Are there any clinical trials combining high-dose IV vitamin C with chemotherapy that I might be eligible for?"

3. "What is your perspective on IV vitamin C as a complementary therapy alongside standard treatment?"

4. "If I'm interested in this approach, what would the protocol look like — dosing, frequency, monitoring?"

5. "Are there any contraindications for me personally (kidney function, other conditions) that would make IV vitamin C unsafe?"

---

Where to Find Clinical Trials

• ClinicalTrials.gov — search "vitamin C pancreatic cancer"
• Let's Win Pancreatic Cancer Trial Finder — curated list of active pancreatic cancer trials
• Ask your oncologist directly about trials at their institution

---

Key Takeaway

According to NCCN Guidelines and emerging research, precision medicine for pancreatic cancer is evolving. While high-dose IV vitamin C combined with chemotherapy shows promise in early trials, it's not yet standard of care. The approach appears most relevant for patients with KRAS-mutant tumors who are willing to participate in clinical research.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.